These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 18078389)
1. The nurse specialist and practical issues in the care of pulmonary arterial hypertension patients. Housten-Harris T Int J Clin Pract Suppl; 2007 Dec; (158):10-8. PubMed ID: 18078389 [TBL] [Abstract][Full Text] [Related]
2. Epoprostenol therapy for primary pulmonary hypertension. Cheever KH; Kitzes B; Genthner D Crit Care Nurse; 1999 Aug; 19(4):20-7. PubMed ID: 10614244 [TBL] [Abstract][Full Text] [Related]
3. Intravenous epoprostenol: a new therapy for primary pulmonary hypertension. Sabo JA; Nord CP Crit Care Nurse; 2000 Dec; 20(6):31-40. PubMed ID: 11878257 [No Abstract] [Full Text] [Related]
4. Prostacycline (Flolan). Intravenous nursing responsibilities in the care of the patient with primary pulmonary hypertension. Benvenuto DB J Intraven Nurs; 1999; 22(5):267-72. PubMed ID: 10776190 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study. Bendayan D; Shitrit D; Kramer MR Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891 [TBL] [Abstract][Full Text] [Related]
9. The experiences of patients with pulmonary arterial hypertension receiving continuous intravenous infusion of epoprostenol (Flolan) and their support persons. Hall H; Côté J; McBean A; Purden M Heart Lung; 2012; 41(1):35-43. PubMed ID: 21784527 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of pulmonary arterial hypertension: Implications for respiratory care. Levine DJ Respir Care; 2006 Apr; 51(4):368-81. PubMed ID: 16563191 [TBL] [Abstract][Full Text] [Related]
14. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729 [TBL] [Abstract][Full Text] [Related]
15. Advances in prostacyclin therapy for pulmonary arterial hypertension. Eells PL Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310 [No Abstract] [Full Text] [Related]
16. The search for an oral prostanoid to treat pulmonary arterial hypertension continues. Are we getting any closer? Rich J; Hoeper MM Int J Clin Pract Suppl; 2009 Mar; (161):17-8. PubMed ID: 19178601 [TBL] [Abstract][Full Text] [Related]
17. [Education of patients treated with a continuous epoprostenol infusion for pulmonary hypertension]. Marlier D Soins; 2006 May; (705 Suppl):S7-12. PubMed ID: 16771257 [No Abstract] [Full Text] [Related]
18. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients. Hsu CH; Gomberg-Maitland M; Glassner C; Chen JH Int J Clin Pract Suppl; 2011 Aug; (172):6-14. PubMed ID: 21736676 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Zlupko M; Harhay MO; Gallop R; Shin J; Archer-Chicko C; Patel R; Palevsky HI; Taichman DB Respir Med; 2008 Oct; 102(10):1431-8. PubMed ID: 18617379 [TBL] [Abstract][Full Text] [Related]
20. Nebulized milrinone use in a pulmonary hypertensive crisis. Buckley MS; Feldman JP Pharmacotherapy; 2007 Dec; 27(12):1763-6. PubMed ID: 18041894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]